Immediate Impact

1 by Nobel laureates 56 standout
Sub-graph 1 of 24

Citing Papers

Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial
2024 Standout
The crosstalk between macrophages and cancer cells potentiates pancreatic cancer cachexia
2024 Standout
2 intermediate papers

Works of J.F. Seitz being referenced

Bevacizumab (Bev) or cetuximab (Cet) plus chemotherapy after progression with bevacizumab plus chemotherapy in patients with wild-type (WT) KRAS metastatic colorectal cancer (mCRC): Final analysis of a French randomized, multicenter, phase II study (PRODIGE 18)
2017
BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer
2012

Author Peers

Author Last Decade Papers Cites
J.F. Seitz 277 148 88 89 29 359
Jamil Asselah 208 114 110 85 29 351
Quoc Riccardo Bao 300 109 156 81 33 388
Liusheng Wu 131 178 80 74 22 362
A. Iop 274 149 60 67 21 362
Yuming Rong 173 101 77 118 43 334
Alper Can 222 142 52 58 29 327
Julien Volet 259 118 108 94 22 358
Liberato Di Lullo 189 109 69 75 24 319
Toshiya Takeda 245 138 164 52 24 370
Long Bin Jeng 139 137 225 59 23 406

All Works

Loading papers...

Rankless by CCL
2026